Ansa

Current synthetic DNA synthesis relies on outdated, chemical-based methods. Ansa Biotechnologies is building a next-generation, enzyme-based technology for DNA synthesis that’s faster, cleaner, and more accurate than existing methods. This novel approach promises to dramatically accelerate innovation across every industry enabled by synthetic DNA, from diagnostics to developing and manufacturing biologic drugs.